Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia

Robert Rosenblatt, Alexander Valdman, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi, Peter Ekman, Lars Egevad

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

OBJECTIVE: To investigate the prognostic value of endothelin-1 (ET-1), a vasoconstrictor involved in differentiation and growth of cancer, in prostate cancer. STUDY DESIGN: A tissue microarray was constructed of 287 prostate cancers from radical prostatectomy (RP) specimens with median follow-up of 48.9 months. Slides were immunostained for ET-1. Intensity and extent of immunoreactivity and their product (IRp) were evaluated. We separately arrayed benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and prostate cancer from 40 men. RESULTS: ET-1 expression was stronger in both HGPIN and cancer than in benign tissue (p<0.001). The intensity and the IRp of ET-1 predicted biochemical recurrence (p<0.001 and p=0.044, respectively), while the staining extent showed no significant correlation with outcome (p=0.68). Recurrence-free survival in patients with strong ET-1 staining was shorter than in those with weaker expression (hazard ratio [CI 95%] 2.44 [1.55-3.84], p<0.001). In a multivariate analysis including ET-1 expression, preoperative serum prostatespecific antigen (PSA), extraprostatic extension, margin status, seminal vesicle invasion and Gleason score, only PSA, margins and Gleason score remained significant. CONCLUSION: ET-1 is overexpressed in localized prostate cancer and predicts outcome after RP in univariate analysis.

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalAnalytical and Quantitative Cytology and Histology
Volume31
Issue number3
StatePublished - Jun 2009

Fingerprint

Prostatic Intraepithelial Neoplasia
Endothelin-1
Prostatic Neoplasms
Neoplasm Grading
Prostatectomy
Staining and Labeling
Antigens
Recurrence
Seminal Vesicles
Vasoconstrictor Agents
Atrophy
Multivariate Analysis
Survival
Growth
Serum

Keywords

  • Endothelin type 1
  • Immunohistochemistry
  • Prostate neoplasms

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Rosenblatt, R., Valdman, A., Cheng, L., Lopez-Beltran, A., Montironi, R., Ekman, P., & Egevad, L. (2009). Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia. Analytical and Quantitative Cytology and Histology, 31(3), 137-142.

Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia. / Rosenblatt, Robert; Valdman, Alexander; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo; Ekman, Peter; Egevad, Lars.

In: Analytical and Quantitative Cytology and Histology, Vol. 31, No. 3, 06.2009, p. 137-142.

Research output: Contribution to journalArticle

Rosenblatt, R, Valdman, A, Cheng, L, Lopez-Beltran, A, Montironi, R, Ekman, P & Egevad, L 2009, 'Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia', Analytical and Quantitative Cytology and Histology, vol. 31, no. 3, pp. 137-142.
Rosenblatt, Robert ; Valdman, Alexander ; Cheng, Liang ; Lopez-Beltran, Antonio ; Montironi, Rodolfo ; Ekman, Peter ; Egevad, Lars. / Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia. In: Analytical and Quantitative Cytology and Histology. 2009 ; Vol. 31, No. 3. pp. 137-142.
@article{9ea141b4771d47389c8266c9ae1af9fa,
title = "Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia",
abstract = "OBJECTIVE: To investigate the prognostic value of endothelin-1 (ET-1), a vasoconstrictor involved in differentiation and growth of cancer, in prostate cancer. STUDY DESIGN: A tissue microarray was constructed of 287 prostate cancers from radical prostatectomy (RP) specimens with median follow-up of 48.9 months. Slides were immunostained for ET-1. Intensity and extent of immunoreactivity and their product (IRp) were evaluated. We separately arrayed benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and prostate cancer from 40 men. RESULTS: ET-1 expression was stronger in both HGPIN and cancer than in benign tissue (p<0.001). The intensity and the IRp of ET-1 predicted biochemical recurrence (p<0.001 and p=0.044, respectively), while the staining extent showed no significant correlation with outcome (p=0.68). Recurrence-free survival in patients with strong ET-1 staining was shorter than in those with weaker expression (hazard ratio [CI 95{\%}] 2.44 [1.55-3.84], p<0.001). In a multivariate analysis including ET-1 expression, preoperative serum prostatespecific antigen (PSA), extraprostatic extension, margin status, seminal vesicle invasion and Gleason score, only PSA, margins and Gleason score remained significant. CONCLUSION: ET-1 is overexpressed in localized prostate cancer and predicts outcome after RP in univariate analysis.",
keywords = "Endothelin type 1, Immunohistochemistry, Prostate neoplasms",
author = "Robert Rosenblatt and Alexander Valdman and Liang Cheng and Antonio Lopez-Beltran and Rodolfo Montironi and Peter Ekman and Lars Egevad",
year = "2009",
month = "6",
language = "English",
volume = "31",
pages = "137--142",
journal = "Analytical and Quantitative Cytopathology and Histopathology",
issn = "0301-102X",
publisher = "John Rylands University Library",
number = "3",

}

TY - JOUR

T1 - Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia

AU - Rosenblatt, Robert

AU - Valdman, Alexander

AU - Cheng, Liang

AU - Lopez-Beltran, Antonio

AU - Montironi, Rodolfo

AU - Ekman, Peter

AU - Egevad, Lars

PY - 2009/6

Y1 - 2009/6

N2 - OBJECTIVE: To investigate the prognostic value of endothelin-1 (ET-1), a vasoconstrictor involved in differentiation and growth of cancer, in prostate cancer. STUDY DESIGN: A tissue microarray was constructed of 287 prostate cancers from radical prostatectomy (RP) specimens with median follow-up of 48.9 months. Slides were immunostained for ET-1. Intensity and extent of immunoreactivity and their product (IRp) were evaluated. We separately arrayed benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and prostate cancer from 40 men. RESULTS: ET-1 expression was stronger in both HGPIN and cancer than in benign tissue (p<0.001). The intensity and the IRp of ET-1 predicted biochemical recurrence (p<0.001 and p=0.044, respectively), while the staining extent showed no significant correlation with outcome (p=0.68). Recurrence-free survival in patients with strong ET-1 staining was shorter than in those with weaker expression (hazard ratio [CI 95%] 2.44 [1.55-3.84], p<0.001). In a multivariate analysis including ET-1 expression, preoperative serum prostatespecific antigen (PSA), extraprostatic extension, margin status, seminal vesicle invasion and Gleason score, only PSA, margins and Gleason score remained significant. CONCLUSION: ET-1 is overexpressed in localized prostate cancer and predicts outcome after RP in univariate analysis.

AB - OBJECTIVE: To investigate the prognostic value of endothelin-1 (ET-1), a vasoconstrictor involved in differentiation and growth of cancer, in prostate cancer. STUDY DESIGN: A tissue microarray was constructed of 287 prostate cancers from radical prostatectomy (RP) specimens with median follow-up of 48.9 months. Slides were immunostained for ET-1. Intensity and extent of immunoreactivity and their product (IRp) were evaluated. We separately arrayed benign prostatic tissue, atrophy, high grade prostatic intraepithelial neoplasia (HGPIN) and prostate cancer from 40 men. RESULTS: ET-1 expression was stronger in both HGPIN and cancer than in benign tissue (p<0.001). The intensity and the IRp of ET-1 predicted biochemical recurrence (p<0.001 and p=0.044, respectively), while the staining extent showed no significant correlation with outcome (p=0.68). Recurrence-free survival in patients with strong ET-1 staining was shorter than in those with weaker expression (hazard ratio [CI 95%] 2.44 [1.55-3.84], p<0.001). In a multivariate analysis including ET-1 expression, preoperative serum prostatespecific antigen (PSA), extraprostatic extension, margin status, seminal vesicle invasion and Gleason score, only PSA, margins and Gleason score remained significant. CONCLUSION: ET-1 is overexpressed in localized prostate cancer and predicts outcome after RP in univariate analysis.

KW - Endothelin type 1

KW - Immunohistochemistry

KW - Prostate neoplasms

UR - http://www.scopus.com/inward/record.url?scp=67849124048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67849124048&partnerID=8YFLogxK

M3 - Article

C2 - 19634784

AN - SCOPUS:67849124048

VL - 31

SP - 137

EP - 142

JO - Analytical and Quantitative Cytopathology and Histopathology

JF - Analytical and Quantitative Cytopathology and Histopathology

SN - 0301-102X

IS - 3

ER -